[1] DZIEWIERZ A, SIUDAK Z, TOKAREK T, et al. Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry)[J]. Int J Cardiol, 2016, 223(1): 236-238. [2] ZHANG C J, DENG Y Z, LEI Y H, et al. The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment[J]. Eur Rev Med Pharmacol Sci, 2018, 22(7): 2169-2174. [3] CELIK T, KAYA M G, AKPEK M, et al. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction[J]. Angiology, 2015, 113(7): 155-162. [4] GU G, XING H, ZHOU Y, et al. Inverse correlation between left ventricular end-diastolic pressure and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention[J]. Clin Exp Nephrol, 2017, 22(8): 808-814. [5] SAMADOV F, YESILDAG O, SARI I, et al. Influence of collaterals on the left ventricular end-diastolic pressure and serum NT-proBNP levels in patients with coronary chronic total occlusion[J]. Egypt Heart J, 2017, 69(2): 127-132. [6] MATSUSHITA K, BALLEW S H, SANG Y, et al. Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study[J]. Atherosclerosis, 2017, 257(1): 208-215. [7] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393. [8] PAPAPOSTOLOU S, ANDRIANOPOULOS N, DUFFY S J, et al. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multi-center Australian registry[J]. EuroIntervention, 2017, 14(2): S181-S181. [9] BALTA S, CELIK T, OZTURK C, et al. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction[J]. Am J Emerg Med, 2016, 34(8): 1542-1547. [10] 贾静静,董平栓,杜来景,等. 左心室舒张末期压力对行介入治疗的急性ST段抬高型心肌梗死患者的预后价值[J].中国循环杂志,2015,30(6):543-546. [11] UNLU M, YILDIRIM A O, DEMIR M, et al. Ankle-brachial index and cardiovascular outcome[J]. Angiology, 2016, 67(2): 193. [12] ORGAN N M, CATHERINE H. How to perform the ankle brachial index test in clinical practice[J]. Med J Aust, 2017, 207(2):60-61. [13] RADA C, OUMMOU S, MERZOUK F, et al. Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk[J]. J Mal Vasc, 2016, 41(6): 353-357. |